Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 278 Carcinoma, Non-Small-Cell Lung 228 Prostatic Neoplasms 183 Neoplasms 180 Multiple Myeloma 140 Lung Neoplasms 137 Neoplasm Metastasis 104 Colorectal Neoplasms 101 Melanoma 87 Ovarian Neoplasms 86 Leukemia, Myeloid, Acute 78 Pancreatic Neoplasms 73 Lymphoma 72 Leukemia, Lymphocytic, Chronic, B-Cell 67 Carcinoma, Renal Cell 65 Squamous Cell Carcinoma of Head and Neck 64 Lymphoma, Non-Hodgkin 64 Brain Neoplasms 64 Recurrence 57 Urinary Bladder Neoplasms 56 Carcinoma, Hepatocellular 56 Hematologic Neoplasms 55 Head and Neck Neoplasms 55 Triple Negative Breast Neoplasms 52 Lymphoma, Follicular 49 Glioblastoma 49 Endometrial Neoplasms 48 Uterine Cervical Neoplasms 47 Precursor Cell Lymphoblastic Leukemia-Lymphoma 47 Sarcoma 44

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Breast Cancer Recurrent × 90 days × Clear all

NCT03820830 2026-04-09

POLAR

ETOP IBCSG Partners Foundation

Phase 3 Active not recruiting

Breast Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon ⚡